Prevention of non-response to cardiac resynchronization therapy requires multidisciplinary efforts focusing on preoperative patient selection, optimal electrode implantation, and postoperative management.
Preventing non-response to cardiac resynchronization therapy requires comprehensive, multidisciplinary efforts spanning patient selection, precise electrode placement, and rigorous postoperative management.
Cardiac resynchronization therapy (CRT) is an important and effective therapy for end-stage heart failure. Non-response to CRT is one of the main obstacles to its application in clinical practice. There is no uniform consensus or definition of CRT "response." Clinical symptoms, ventricular remodeling indices, and cardiovascular events have been reported to be associated with non-responders. To prevent non-response to CRT, three aspects should be thoroughly considered: preoperative patient selection, electrode implantation, and postoperative management. Preoperative selection of appropriate patients for CRT treatment is an important step in preventing non-response. Currently, the CRT inclusion criteria are mainly based on the morphology of QRS waves in deciding ventricular dyssynchrony. Echocardiography and cardiac magnetic resonance are being explored to predict nonresponse to CRT. The location of left ventricular electrode implantation is a current hot spot of research; it is important to identify the location of the latest exciting ventricular segment and avoid scars. Cardiac magnetic resonance and ultrasonic spot tracking are being progressively developed in this field. Some new techniques such as His Bundle pacing, endocardial electrodes, and novel sensors are also being investigated. Postoperative management of patients is another essential step towards preventing non-response; it mainly focuses on the treatment of the disease itself and CRT program control optimization. CRT treatment is just one part of the overall treatment of heart failure, and multidisciplinary efforts are needed to improve the overall outcome.
Zhu et al. (Sat,) conducted a review in End-stage heart failure. Cardiac resynchronization therapy (CRT) was evaluated. Prevention of non-response to cardiac resynchronization therapy requires multidisciplinary efforts focusing on preoperative patient selection, optimal electrode implantation, and postoperative management.